Aβ is shown to decrease brain PKC levels and activity (Lee et al., 2004; Liron et al., 2007; Hongpaisan et al., 2011), while PKC hypofunction conversely leads to the defects of APP processing and significantly contributes to AD pathophysiology and progression (Pascale et al., 1998). The gene discussed is APP; the disease is Alzheimer disease.